Mood Disorders Psychopharmacology Unit

71 posts

Mood Disorders Psychopharmacology Unit

@MDPU_TWH

"We are an academic mood disorders research centre, providing leadership in translational research and novel opportunity treatment worldwide" #BehindTheLabel

Toronto Western Hospital Katılım Kasım 2021

148 Takip Edilen193 Takipçiler

Sabitlenmiş Tweet

Mood Disorders Psychopharmacology Unit@MDPU_TWH·13 Mar

Are you a healthy individual interested in clinical research? We're currently recruiting healthy participants for a clinical trial at Toronto Western Hospital. For more details, please contact us at mdpu@uhn.ca or 416-603-5800 (ext. 5633).

Mood Disorders Psychopharmacology Unit tweet media

English

1.5K

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·22 Mar

See our report on the Antidepressant Effects of #Psilocybin in the Absence of #Psychedelic Effects @APAPubJournals We present the first in-human evidence to support antidepressant effects of psilocybin independent of 5HT2A and psychedelic effects 1/4 pubmed.ncbi.nlm.nih.gov/36945824/

English

13.5K

Mood Disorders Psychopharmacology Unit retweetledi

Danica Johnson (she/her)@DanicaEJohnson·24 Mar

Very excited about my first first-author publication! I’m grateful to be part of such an amazing lab. Many thanks to my supervisor @JD_Rosenblat for his continued support and mentorship.

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat

Congratulations to Danica Johnson @MDPU_TWH @UofTPsych: An update on potential pharmacotherapies for cognitive impairment in bipolar disorder FYI Danica is studying the effect of #ketamine and #psilocybin on cognitive function so more to come! tandfonline.com/doi/abs/10.108…

English

1.7K

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·24 Mar

English

3.3K

Mood Disorders Psychopharmacology Unit retweetledi

Roger S. McIntyre, MD, FRCPC@rogersmcintyre·22 Mar

Very interesting case lead by Dr Josh Rosenblat from our team that the use of a 5HTA antagonist with psilocybin did not attenuate antidepressant effect in TRD raises interesting conceptual questions on mechanisms of psilocybin effects . pubmed.ncbi.nlm.nih.gov/36945824/

English

112

45.4K

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·21 Mar

Congrats Dr Lee @MDPU_TWH @UHN_Research @UofTPsych on another great paper Association of a low protein diet with depressive symptoms and poor health-related quality of life in CKD 50 day free full text Link: authors.elsevier.com/c/1gnOZ55vZ9qk1

English

892

Mood Disorders Psychopharmacology Unit@MDPU_TWH·13 Mar

Do you have a clinical diagnosis of Major Depressive Disorder or Bipolar Disorder? We're currently recruiting participants for a clinical trial at Toronto Western Hospital. For more details, please contact us at mdpu@uhn.ca or 416-603-5800 (ext. 5633).

English

153

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·7 Mar

Real World Effectiveness of Repeated #Ketamine Infusions for Treatment-Resistant #Depression with Comorbid #Borderline Personality Disorder 50 days #free access to full text: authors.elsevier.com/a/1giOFbZg7M9mF

English

4.4K

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·6 Mar

Congrats to our excellent summer student Kevork @UofTPsych on this important analysis: Effectiveness of #Ketamine for Treatment-Resistant Depression with Comorbid Borderline Personality Disorder (BDP) Ketamine reduced symptoms of both BPD + Depression sciencedirect.com/science/articl…

English

1.6K

Mood Disorders Psychopharmacology Unit retweetledi

Brain and Cognition Discovery Foundation (BCDF)@BCDFoundation·16 Kas

Congratulations to our very own Dr. @rogersmcintyre, the Chairman & Executive Director of the @BCDFoundation, and all the other @UHN researchers who have made the 2022 list of Highly Cited Researchers from @Clarivate! 👏 uhnresearch.ca/news/world-lea… @MDPU_TWH @UofTPsych #research

English

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·28 Eki

⁦@MDPU_TWH⁩ representing ⁦@CPA_APC⁩ !

Joshua Rosenblat, MD, MSc, FRCPC tweet media

English

Mood Disorders Psychopharmacology Unit retweetledi

Shakila Meshkat@shakilameshkat·2 Eki

Happy to see our article published in Psychiatry Research. I am grateful to @JD_Rosenblat for their insightful supervision on this project and for all the help and support. sciencedirect.com/science/articl…

English

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·7 Eyl

Great to see all the wonderful work happening @UofTPsych this year. Also grateful for our #psilocybin research to be featured in the Annual Report. Advancing Treatments in Psychiatry psychiatry.utoronto.ca/news/advancing…

English

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·7 Eyl

Huge congrats to Anastasia Levinta, a talented resident @UofTPsych who did an elective with @MDPU_TWH last year & wrote this important report: The association between stage of treatment-resistant #depression & clinical utility of #ketamine 50d #free FT authors.elsevier.com/a/1firKbXYinOlr

English

Mood Disorders Psychopharmacology Unit retweetledi

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat·17 Ağu

See our national @CANMAT_org guidelines on #psychedelics out today @TheCJPsych We hope this report will provide a helpful summary and guidance for clinicians, researchers, patients, regulators and stakeholders. 1/3 doi.org/10.1177%2F0706…

English

Mood Disorders Psychopharmacology Unit retweetledi

Roger S. McIntyre, MD, FRCPC@rogersmcintyre·17 Ağu

Congratulations to Dr. Josh Rosenblat in leading the team on this very important campaign On behalf of CANMAT providing guidelines for psychedelics the first such guideline globally! pubmed.ncbi.nlm.nih.gov/35975555/

English

Mood Disorders Psychopharmacology Unit retweetledi

Youshay Jawad@youshayjwd·10 Ağu

I am excited to have a public discussion around loneliness with my mentor @rogersmcintyre. Loneliness is just as dangerous as any other physical or mental ailment and can have far-reaching health consequences. 🔗 For twitter space. Join to get a reminder! twitter.com/i/spaces/1lPKq…

English

Mood Disorders Psychopharmacology Unit@MDPU_TWH·4 Ağu

Read our latest publication about Active mechanisms of ketamine-assisted psychotherapy: A systematic review🔻 #psychotherapy #mentalhealthishealth ⁦@UofT⁩ ⁦@UofTPsych⁩ sciencedirect.com/science/articl…

English

Mood Disorders Psychopharmacology Unit@MDPU_TWH·4 Ağu

New paper alert🚨#Psychiatry #ketamine #psychotherapy

Joshua Rosenblat, MD, MSc, FRCPC@JD_Rosenblat

Congrats on an excellent paper, Isak! Isak also did a great job helping us launch our psilocybin trail last year @braxiahq Active mechanisms of #ketamine-assisted psychotherapy: A systematic review 50 days' free full text: authors.elsevier.com/c/1fWvfbXYinOUm

English

Mood Disorders Psychopharmacology Unit retweetledi

Shakila Meshkat@shakilameshkat·4 Ağu

I’m happy to be a part of this excellent paper by Isak. Read our latest review about active mechanisms of #ketamine assisted #psychotherapy. sciencedirect.com/science/articl…

English

Keşfet

@APAPubJournals @JD_Rosenblat @UofTPsych @UHN_Research @rogersmcintyre @BCDFoundation @UHN @Clarivate